Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,430,543,942
+$565,488,742 QoQ
Shares Held
25,554,538
-0.4% QoQ
Ownership
1.45%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#9
of 4,138 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORGES BANK holds $48,449,655,630 across 13 Drug Manufacturers - General names. ABBV ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,471,413 | $13,759,158,041 | |
| 2 | JNJ |
Johnson & Johnson
|
31,825,084 | $8,082,616,583 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
25,554,538 | $6,430,543,942 | |
| 4 | AZN |
Astrazeneca PLC
|
33,864,172 | $6,421,324,294 | |
| 5 | MRK |
Merck & Co., Inc.
|
36,983,784 | $4,752,416,244 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,965,555 | $2,775,128,218 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,866,658 | $2,124,256,833 | |
| 8 | AMGN |
Amgen Inc
|
5,625,584 | $2,037,136,478 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,430,543,942 | 25,554,538 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $5,865,055,200 | 25,668,761 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $4,288,200,107 | 23,102,037 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,132,365,044 | 24,495,824 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $4,459,385,054 | 25,095,020 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,537,132,029 | 22,975,147 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $3,855,506,316 | 22,478,465 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,017,994,434 | 22,064,769 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $3,229,888,304 | 20,842,023 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,049,247,678 | 20,456,512 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $2,741,422,043 | 20,347,525 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $3,142,049,672 | 19,715,440 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $3,033,347,945 | 18,769,556 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,385,215,417 | 17,772,263 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $2,650,186,446 | 17,303,385 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $2,874,918,396 | 17,734,368 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $2,433,268,525 | 17,970,964 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $1,958,218,152 | 18,153,501 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $2,062,622,228 | 18,311,632 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $2,032,366,838 | 18,779,956 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $2,070,985,127 | 19,327,906 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $1,592,969,549 | 18,186,660 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $1,844,502,260 | 18,786,945 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $1,130,058,918 | 14,832,116 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||